World Heart Corporation, together with its subsidiaries, focuses on the development and commercialization of implantable ventricular assist devices (VADs) for adults, children, and infants suffering from heart failure in the United States. The VADs are mechanical assist devices that supplement the circulatory function of the heart by re-routing blood flow through a mechanical pump allowing for the restoration of normal blood circulation. The company’s products in development include PediaFlow VAD, which is a small magnetically levitated axial rotary VAD intended for use in infants and children; and MiFlow VAD, a miniature maglev rotary pump, intended to provide partial to full circulatory su...
4750 Wiley Post Way
Salt Lake City, UT 84116
Founded in 1996
World Heart Corporation Announces Management Changes; Amends Certificate of Incorporation and Bylaws
Aug 3 12
On August 2, 2012, World Heart Corporation completed its merger with Ocean Acquisition Holding Inc. (merger sub), an indirect wholly owned subsidiary of HeartWare International Inc. The merger was effected pursuant to an agreement and plan of merger and reorganization, dated as of March 29, 2012, entered into among World Heart, merger sub and HeartWare (merger agreement). The merger agreement was adopted by the company's stockholders at a special meeting of the company's stockholders held on August 2, 2012. The merger became effective after the close of business on August 2, 2012 (effective time), pursuant to the Certificate of merger that was filed with the Secretary of State of the State of Delaware on that date. In the merger, merger sub merged with and into the company and the company continued as the surviving corporation and as an indirect wholly owned subsidiary of HeartWare. In connection with the merger, all members of the company's Board of Directors (John Alexander Martin, Jeani Delagardelle, Michael Sumner Estes, Ph.D., William C. Garriock, Anders D. Hove, M.D., Eugene B. Jones and Austin W. Marxe) resigned as of the effective time, and the directors of merger sub immediately prior to the effective time (Douglas Godshall and Lawrence Knopf) became the directors of the company immediately after the effective time. In addition, in connection with the merger, Morgan R. Brown, the company's Executive Vice President and Chief Financial Officer, resigned as of the effective time, and the officers of merger sub immediately prior to the effective time (Douglas Godshall, Peter McAree, Lawrence Knopf, Jeffrey LaRose and Lauren Farrell) became the officers of the company immediately after the effective time.
Pursuant to the merger agreement, at the effective time, the Certificate of Incorporation of the company was amended and restated to be in the form of the Certificate of Incorporation of merger sub. Pursuant to the merger agreement, at the effective time, the bylaws of the company were amended and restated to be in the form of the bylaws of merger sub.
World Heart Corp.(NasdaqCM:WHRT) dropped from NASDAQ Composite Index
Aug 2 12
World Heart Corp. will be removed from NASDAQ Composite Index